Envoy Medical CEO to Present at Virtual Investor Frum on June 12th.
PorAinvest
miércoles, 11 de junio de 2025, 8:36 am ET1 min de lectura
COCH--
The virtual forum will feature a live presentation by CEO Lucas, followed by a Q&A session where investors can ask questions in real-time. For those unable to attend the live event, a recorded webcast will be made available after the event. The event will also offer one-on-one meeting opportunities with Envoy Medical representatives from June 12th through June 17th [1].
Envoy Medical is known for its fully implanted hearing devices, including the Esteem® active middle ear implant and the fully implanted Acclaim® cochlear implant. The Esteem device, approved by the FDA, offers 24/7 hearing capability using the ear's natural anatomy, while the Acclaim cochlear implant is an investigational device that leverages the ear's natural anatomy to capture sound [1].
The company has recently achieved significant milestones in its clinical trials for the Acclaim cochlear implant, which is expected to address severe to profound sensorineural hearing loss not adequately addressed by hearing aids [1]. The Acclaim CI received the Breakthrough Device Designation from the FDA in 2019, highlighting its potential to revolutionize hearing technology [1].
Investors interested in attending the event are encouraged to pre-register and run an online system check to expedite participation and receive event updates. The event will be held at www.virtualinvestorconferences.com [1].
References:
[1] https://www.globenewswire.com/news-release/2025/06/11/3097537/0/en/Envoy-Medical-to-Present-at-the-Life-Sciences-Virtual-Investor-Forum-June-12th.html
Envoy Medical, a hearing health company, announced CEO Brent Lucas will present at the Life Sciences Virtual Investor Frum on June 12th. The event will be live and interactive, allowing investors to ask questions in real-time. A recorded webcast will also be available for those unable to attend.
Envoy Medical, Inc. (NASDAQ: COCH), a pioneering hearing health company, has announced that its CEO, Brent Lucas, will present at the upcoming Life Sciences Virtual Investor Forum on June 12th, 2025. The event, hosted by VirtualInvestorConferences.com, will provide an interactive platform for investors to engage with the company and learn more about its innovative hearing technologies [1].The virtual forum will feature a live presentation by CEO Lucas, followed by a Q&A session where investors can ask questions in real-time. For those unable to attend the live event, a recorded webcast will be made available after the event. The event will also offer one-on-one meeting opportunities with Envoy Medical representatives from June 12th through June 17th [1].
Envoy Medical is known for its fully implanted hearing devices, including the Esteem® active middle ear implant and the fully implanted Acclaim® cochlear implant. The Esteem device, approved by the FDA, offers 24/7 hearing capability using the ear's natural anatomy, while the Acclaim cochlear implant is an investigational device that leverages the ear's natural anatomy to capture sound [1].
The company has recently achieved significant milestones in its clinical trials for the Acclaim cochlear implant, which is expected to address severe to profound sensorineural hearing loss not adequately addressed by hearing aids [1]. The Acclaim CI received the Breakthrough Device Designation from the FDA in 2019, highlighting its potential to revolutionize hearing technology [1].
Investors interested in attending the event are encouraged to pre-register and run an online system check to expedite participation and receive event updates. The event will be held at www.virtualinvestorconferences.com [1].
References:
[1] https://www.globenewswire.com/news-release/2025/06/11/3097537/0/en/Envoy-Medical-to-Present-at-the-Life-Sciences-Virtual-Investor-Forum-June-12th.html
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema
SOBRE NOSOTROS
Nuestra historiaAutores de noticiasBase de conocimientosPolítica de privacidadTérmino de usoDescargo de responsabilidad de corretaje de tercerosTérminos de uso de AIMEDivulgaciones de riesgos de AInvest AICarrerasCONTÁCTENOS
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comentarios
Aún no hay comentarios